Access Bio

엑세스바이오 인코퍼레이션 · KOSDAQ · 950130 · Industry: Manufacture of medical supplies and related other medicaments

Key metrics

Earnings

Revenue, Q3 2026₩10m As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+47.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+277.5% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩5m As of Sep 30, 2026 Source 1 ↗
Operating income QoQ+66.7% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY+45.8% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩39.3bn As of Apr 30, 2026 Source 1 ↗
Treasury shares cancelled (number), last 12 months2,553,998 shares As of Apr 30, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months, % of shares7.3% As of Apr 30, 2026 Source 1 ↗, Source 2 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩5.0bn As of Oct 20, 2026 Source 1
Supply contracts vs prior-year revenue22597.4% As of Oct 20, 2026 Source 1
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months1 As of Nov 19, 2026
DART filings, previous 3 months3 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

No insider transactions in the last 12 months.

Annual financials

YearRevenueOperating income
2025₩22m-₩45m
2024₩82m-₩3m
2023₩267m₩17m

Filing timeline